TinyGemsBreaks – Kairos Pharma Ltd. (NYSE American: KAPA) Sets Virtual Annual Meeting, Discloses Going Concern Notice
Kairos Pharma (NYSE American: KAPA) announced that its annual meeting of shareholders will be held virtually at 9 a.m. PDT on June 29, 2026, with meeting materials to be mailed following finalization and filing with the SEC. The clinical-stage biopharmaceutical company also disclosed that its 2025 annual report included an audit report containing a going concern explanatory paragraph from its independent registered public accounting firm, as required under Section 610(b) of the NYSE American Company Guide, noting the disclosure does not reflect any change or amendment to previously filed financial statements. To view the full press release, visit https://ibn.fm/sQ0pm About…

